Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 2,411 shares at $77.48 ($186K) on 2026-01-07, disclosed to the SEC on 2026-01-08.
Seasonal sale ($186k) by CHIEF TECHNICAL Operations OFFICER — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.95 | 54 | $4K | 2.2% |
| 2 | $76.95 | 1,279 | $98K | 52.9% |
| 3 | $77.48 | 52 | $4K | 2.2% |
| 4 | $77.48 | 1,026 | $79K | 42.7% |
| Total | $77.19 avg | 2,411 | $186K | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |